State Street Corporation 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 11:13 am Sale | 2024-09-30 | 13G | Akero Therapeutics, Inc. AKRO | STATE STREET CORP STT | 2,502,946 3.600% | -2,619,949 (-51.14%) | Filing |
| 2024-01-25 09:36 am Purchase | 2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO | STATE STREET CORP STT | 5,122,895 9.200% | 2,621,926 (+104.84%) | Filing |
| 2023-02-03 2:06 pm Purchase | 2022-12-31 | 13G | Akero Therapeutics, Inc. AKRO | STATE STREET CORP STT | 2,500,969 5.350% | 2,500,969 (New Position) | Filing |